Upload Avatar (500 x 500)
Li Feng
Bioinformatics Science and Technology
Harbin Medical University
Heilongjiang
Language: Chinese, English
Single-Cell Sequencing
Malignant Tumors
Data Analysis
Non-Coding Rna
Regulatory Pathways
Bioinformatics
Cancer Research
Rna Function
Genomics
Transcriptomics
Areas of Focus
- Single-cell sequencing data analysis of malignant tumors
- Identification and functional study of non-coding RNA regulatory pathways
Work Experience
- 2014-present: Associate Researcher at Harbin Medical University
- 2019-present: Joined the Postdoctoral Research Station in Biology at Harbin Medical University
Academic Background & Achievements
- 2006-2014: Master's in Biomedical Engineering, Harbin Medical University
- 2019: PhD in Biomedical Engineering, Harbin Medical University
- Published 31 SCI papers with a cumulative impact factor over 100
Publications
- A comprehensive overview of oncogenic pathways in human cancer, Li Feng, 2020
- Comprehensive analysis of ncRNA involvement in brain microglia immunology, Li Feng, 2022
- Identifying and characterizing drug sensitivity-related lncRNA-TF-gene regulatory triplets, Li Feng, 2022
- RNAactDrug: a comprehensive database of RNAs associated with drug sensitivity from multi-omics data, Li Feng, 2020
- Identification and comprehensive characterization of lncRNAs with copy number variations and their driving transcriptional perturbed subpathways reveal functional significance for cancer, Li Feng, 2020
- Prognostic Features of the Tumor Immune Microenvironment in Glioma and Their Clinical Applications: Analysis of Multiple Cohorts, Li Feng, 2022
- Dissecting immune cell stat regulation network reveals biomarkers to predict ICB therapy responders in melanoma, Li Feng, 2021
- Identifying individualized risk subpathways reveals pan-cancer molecular classification based on multi-omics data, Li Feng, 2022
- Functional regulations between genetic alteration‑driven genes and drug target genes acting as prognostic biomarkers in breast cancer, Li Feng, 2022
- Identifying subpathway signatures for individualized anticancer drug response by integrating multi-omics data, Li Feng, 2019
Awards
- 2019: Second Prize for Outstanding Scientific Research Achievements in Higher Education Institutions by the Ministry of Education of the People's Republic of China
